Fibrotic Inflammatory Rheumatic Diseases (Nor-FIORD) Publications

  1. Moor CC, Kreuter M, Hoffmann-Vold AM (2025)
    ILA or ILD in CTD: The Alphabet Soup Continues
    Am J Respir Crit Care Med (in press)
    DOI 10.1164/rccm.202506-1373LE, PubMed 41052459
  2. Antoniou KM, Distler O, Gheorghiu AM, Moor CC, Vikse J, Bizymi N, Galetti I, Brown G, Bargagli E, Allanore Y, Corte TJ, Dieudé P, Cottin V, Fisher BA, Fabre A, Giles JT, Kreuter M, Lundberg IE, Poletti V, Maurer B, Renzoni EA, Müller-Ladner U, Strek ME, Sverzellati N, Studenic P et al. (2025)
    ERS/EULAR clinical practice guidelines for connective tissue diseases associated interstitial lung disease
    Ann Rheum Dis (in press)
    DOI 10.1016/j.ard.2025.08.021, PubMed 40912974
  3. Antoniou KM, Distler O, Gheorghiu AM, Moor CC, Vikse J, Bizymi N, Galetti I, Brown G, Bargagli E, Allanore Y, Corte TJ, Dieudé P, Cottin V, Fisher BA, Fabre A, Giles JT, Kreuter M, Lundberg IE, Poletti V, Maurer B, Renzoni EA, Müller-Ladner U, Strek ME, Sverzellati N, Studenic P et al. (2025)
    ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung diseaseDeveloped by the task force for connective tissue disease-associated interstitial lung disease of the European Respiratory Society (ERS) and the European Alliance of Associations for Rheumatology (EULAR)Endorsed by the European Reference Network on rare respiratory diseases (ERN-LUNG)
    Eur Respir J (in press)
    DOI 10.1183/13993003.02533-2024, PubMed 40907995
  4. Trottet C, Schürch M, Allam A, Petelytska L, Castellví I, Bečvář R, de Vries-Bouwstra J, Iannone F, Carreira P, Truchetet ME, Cuomo G, Rezus E, Cantatore FP, Simeón-Aznar CP, Parvu M, Dzhus M, Distler O, Hoffmann-Vold AM, Krauthammer M, EUSTAR Collaborators (2025)
    Deep hierarchical subtyping of multi-organ systemic sclerosis trajectories - a EUSTAR study
    NPJ Digit Med, 8 (1), 563
    DOI 10.1038/s41746-025-01962-y, PubMed 40890392
  5. Goni E, Vikse J, Lanzillotta M, Fevang BS, Midtvedt Ø, Mahajne J, Batani V, Benanti G, Beyer G, Dagna L, Molberg Ø, Norheim KB, Schönermarck U, Regel I, Mayerle J, Hoffmann-Vold AM, Della-Torre E (2025)
    Effectiveness and safety of rituximab across the four phenotypes of IgG4-related disease: a European multi-center cohort study of 115 patients
    Eur J Intern Med, 106459 (in press)
    DOI 10.1016/j.ejim.2025.106459, PubMed 40829952
  6. Hoffmann-Vold AM, Distler O, authors (2025)
    Further progression in patients with systemic sclerosis-associated interstitial lung disease - Authors' reply
    Lancet Rheumatol, 7 (10), e670-e671
    DOI 10.1016/S2665-9913(25)00217-6, PubMed 40816307
  7. Bruni C, Tofani L, Fretheim H, Liem SIE, Velauthapillai A, Bjørkekjær H, Barua I, Galetti I, Garaiman A, Becker MO, Hoffmann-Vold AM, de Vries-Bouwstra J, Vonk MC, Distler JHW, Matucci-Cerinic M, Distler O (2025)
    A screening tool to detect interstitial lung disease in systemic sclerosis: the ILD-RISC Score
    Rheumatology (Oxford) (in press)
    DOI 10.1093/rheumatology/keaf445, PubMed 40811030
  8. Sauer GM, Käs F, Mihai CM, Elhai M, Dobrota R, Becker MO, Muraru S, Hoffmann-Vold AM, Distler O, Bruni C (2025)
    Emphysema elevates the DETECT scores: impact on pulmonary hypertension screening and diagnosis in systemic sclerosis
    Rheumatology (Oxford) (in press)
    DOI 10.1093/rheumatology/keaf410, PubMed 40748717
  9. Dengler H, Vonow-Eisenring M, Becker MO, Dobrota R, Mihai C, Muraru S, Hoffmann-Vold AM, Distler O, Bruni C, Elhai M (2025)
    The serum levels of specific autoantibodies in systemic sclerosis predict a more severe skin involvement
    J Scleroderma Relat Disord, 23971983251357991 (in press)
    DOI 10.1177/23971983251357991, PubMed 40746331
  10. Zheng S, Zhou Z, Du G, Chen Q, Chen S, Lin J, Hu S, Zhang W, Zheng K, Zhuang J, Huang M, Ruaro B, Bruni C, Hoffmann-Vold AM, Matucci-Cerinic M, Furst DE, Wang Y (2025)
    The diagnostic utility of lung ultrasound in the assessment of interstitial lung disease associated with rheumatoid arthritis
    Arthritis Res Ther, 27 (1), 159
    DOI 10.1186/s13075-025-03626-4, PubMed 40739275
  11. Vujasinovic M, Lanzillotta M, Culver EL, Rebours V, Drenth JPH, Stojkovic Lalosevic M, Vikse J, Gubergrits N, Hirth M, Cardinale V, Motta RV, Della-Torre E, Sciberras N, Maida M, Trikola A, Lammert F, Descourvières C, Ponsioen C, Frøkjær JB, Schneider A, Alvaro D, Capurso G, Löhr JM (2025)
    Adherence to United European Gastroenterology Guidelines on Diagnosis and Therapy of Immunoglobulin-G4-Related Digestive Disease
    United European Gastroenterol J, 13 (8), 1583-1592
    DOI 10.1002/ueg2.70081, PubMed 40693827
  12. Sabanovic H, Pauling JD, Baron M, Clemens L, Del Galdo F, Denton CP, Distler O, Frech T, Hoffmann-Vold AM, Hudson M, Khanna D, Maltez N, Medsger TA, Merkel PA, Nikpour M, Pope J, Steen VD, Stevens W, Volkmann ER, Ross L (2025)
    'Am I doing this right?' Physician perceptions of the global assessment in clinical trials of systemic sclerosis
    Rheumatology (Oxford) (in press)
    DOI 10.1093/rheumatology/keaf377, PubMed 40644620
  13. Sobanski V, de Vries-Bouwstra J, Hoffmann-Vold AM, Huscher D, Alves M, Matucci-Cerinic M, Riemekasten G, Li M, Czirják L, Kowal-Bielecka O, Allanore Y, Schoof N, Distler O, (2025)
    Lung function and skin fibrosis changes as predictors of survival in SSc-associated interstitial lung disease: a EUSTAR study
    Rheumatology (Oxford), 64 (10), 5344-5353
    DOI 10.1093/rheumatology/keaf264, PubMed 40457805
  14. Maher TM, Assassi S, Azuma A, Cottin V, Hoffmann-Vold AM, Kreuter M, Oldham JM, Richeldi L, Valenzuela C, Wijsenbeek MS, Clerisme-Beaty E, Coeck C, Gu H, Ritter I, Schlosser A, Stowasser S, Voss F, Weimann G, Zoz DF, Martinez FJ, FIBRONEER-ILD Trial Investigators (2025)
    Nerandomilast in Patients with Progressive Pulmonary Fibrosis
    N Engl J Med, 392 (22), 2203-2214
    DOI 10.1056/NEJMoa2503643, PubMed 40388329
  15. Hoffmann-Vold AM, Petelytska L, Fretheim H, Aaløkken TM, Becker MO, Jenssen Bjørkekjær H, Brunborg C, Bruni C, Clarenbach C, Diep PP, Dobrota R, Durheim MT, Elhai M, Frauenfelder T, Huang S, Jordan S, Langballe E, Midtvedt Ø, Mihai C, Mulcaire-Jones E, Pugashetti JV, Sprecher M, Oldham J, Molberg Ø, Khanna D et al. (2025)
    Predicting the risk of subsequent progression in patients with systemic sclerosis-associated interstitial lung disease with progression: a multicentre observational cohort study
    Lancet Rheumatol, 7 (7), e463-e471
    DOI 10.1016/S2665-9913(25)00026-8, PubMed 40381640
  16. Tschalèr L, Jordan S, Aaløkken TM, Becker M, Brunborg C, Bruni C, Clarenbach C, Dobrota R, Durheim MT, Elhai M, Frauenfelder T, Fretheim H, Garen T, Midtvedt O, Mihai C, Molberg Ø, Distler O, Hoffmann-Vold AM (2025)
    Validation of a semi-quantitative method to assess interstitial lung disease severity and progression in systemic sclerosis by standard and low-dose HRCT scans
    RMD Open, 11 (1)
    DOI 10.1136/rmdopen-2024-004938, PubMed 40021203
  17. Györfi AH, Filla T, Polzin A, Tascilar K, Buch M, Tröbs M, Matei AE, Airo P, Balbir-Gurman A, Kuwert F, Mihai C, Kabala A, Graßhoff H, Callaghan J, Isomura Y, Mansour J, Spierings J, Tennoe AH, Selvi E, Riccieri V, Hoffmann-Vold AM, Bergmann C, Schett G, Hunzelmann N, van Laar JM et al. (2025)
    Evaluation of Systemic Sclerosis Primary Heart Involvement and Chronic Heart Failure in the European Scleroderma Trials and Research Cohort
    J Am Heart Assoc, 14 (5), e036730
    DOI 10.1161/JAHA.124.036730, PubMed 40008525
  18. Buerki K, Toitou M, de Wit M, Grealis S, Ludwig S, Britt C, Klett F, Steeb I, Maletic T, Eisenring A, Timpert-Argust PJ, Diem D, Micheroli R, Dudli S, Bruni C, Camarillo-Retamosa E, Dobrota R, Hoffmann-Vold AM, Ciurea A, Ospelt C, Distler O, Elhai M (2025)
    How to build a framework to establish a patient research partner network in rheumatology research: a report of a 2-year implementation project
    RMD Open, 11 (1)
    DOI 10.1136/rmdopen-2024-005263, PubMed 39929597
  19. Fretheim H, Barua I, Bakland G, Dhainaut A, Halse AK, Carstens MN, Didriksen H, Midtvedt Ø, Lundin KEA, Aabakken L, Sarna VK, Zaré HK, Khanna D, Distler O, Midtvedt T, Bækkevold ES, Olsen IC, Domanska D, Pesonen ME, Molberg Ø, Hoffmann-Vold AM (2025)
    Faecal microbiota transplantation in patients with systemic sclerosis and lower gastrointestinal tract symptoms in Norway (ReSScue): a phase 2, randomised, double-blind, placebo-controlled trial
    Lancet Rheumatol, 7 (5), e323-e332
    DOI 10.1016/S2665-9913(24)00334-5, PubMed 39900089
  20. Yan Q, Bruni C, Garaiman A, Mihai C, Jordan S, Becker MO, Elhai M, Dobrota R, Liubov P, Henes J, Hachulla E, Siegert E, Balbir-Gurman A, Cuomo G, Riemekasten G, Heitmann S, Beigi DMR, Ullman S, Sfikakis P, Ingegnoli F, Bernardino V, Truchetet ME, Vonk M, Galdo FD, Hoffmann-Vold AM et al. (2025)
    Post hoc comparison of the effectiveness of tocilizumab, rituximab, mycophenolate mofetil, and cyclophosphamide in patients with SSc-ILD from the EUSTAR database
    Ann Rheum Dis, 84 (4), 620-631
    DOI 10.1016/j.ard.2025.01.014, PubMed 39894689
  21. Bjørkekjær HJ, Bruni C, Broch K, Brunborg C, Carreira PE, Airò P, Simeón-Aznar CP, Truchetet ME, Giollo A, Balbir-Gurman A, Martin M, Denton CP, Gabrielli A, Del Galdo F, Vonk MC, Fretheim H, Bitter H, Midtvedt Ø, Andreassen A, Høie S, Tanaka Y, Riemekasten G, Müller-Ladner U, Matucci-Cerinic M, Castellví I et al. (2025)
    A comparative analysis of risk stratification tools in SSc-associated pulmonary arterial hypertension: a EUSTAR analysis
    Rheumatology (Oxford), 64 (6), 3643-3656
    DOI 10.1093/rheumatology/keaf053, PubMed 39878955
  22. Del Galdo F, Lescoat A, Conaghan PG, Bertoldo E, Čolić J, Santiago T, Suliman YA, Matucci-Cerinic M, Gabrielli A, Distler O, Hoffmann-Vold AM, Castellví I, Balbir-Gurman A, Vonk M, Ananyeva L, Rednic S, Tarasova A, Ostojic P, Boyadzhieva V, El Aoufy K, Farrington S, Galetti I, Denton CP, Kowal-Bielecka O, Mueller-Ladner U et al. (2025)
    EULAR recommendations for the treatment of systemic sclerosis: 2023 update
    Ann Rheum Dis, 84 (1), 29-40
    DOI 10.1136/ard-2024-226430, PubMed 39874231
  23. Roth E, Bruni C, Petelytska L, Becker MO, Dobrota R, Jordan S, Mihai C, Muraru S, Carreira PE, De Vries-Bouwstra J, Braun-Moscovici Y, Liakouli V, Moroncini G, Bergmann C, Mouthon L, Denton CP, De Santis M, Cauli A, Adler S, Bernardino V, Truchetet ME, Vonk M, Del Galdo F, Hoffmann-Vold AM, Distler O et al. (2025)
    Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort
    Rheumatology (Oxford) (in press)
    DOI 10.1093/rheumatology/keaf016, PubMed 39775478
  24. Aringer M, Distler O, Hoffmann-Vold AM, Kuwana M, Prosch H, Volkmann ER (2024)
    Rationale for phosphodiesterase-4 inhibition as a treatment strategy for interstitial lung diseases associated with rheumatic diseases
    RMD Open, 10 (4)
    DOI 10.1136/rmdopen-2024-004704, PubMed 39719300
  25. Khanna D, de Vries-Bouwstra J, Hoffmann-Vold AM, Kuwana M, Low AHL, Proudman S, Flack M, Kukreja A, Fagan N, Distler O (2024)
    A Phase II study of avenciguat, a novel soluble guanylate cyclase activator, in patients with systemic sclerosis: Study design and rationale of the VITALISScE™ study
    J Scleroderma Relat Disord, 23971983241291923 (in press)
    DOI 10.1177/23971983241291923, PubMed 39544899
  26. Vikse J (2024)
    Revmatisk eller revmatologisk sykdom?
    Tidsskr Nor Laegeforen, 144 (13)
    DOI 10.4045/tidsskr.24.0297, PubMed 39498654
  27. Zhang W, Huang G, Zheng S, Lin J, Hu S, Zhuang J, Zhou Z, Du G, Zheng K, Chen S, Zhang Q, Mikish A, Hoffmann-Vold AM, Kuwana M, Matucci-Cerinic M, Furst DE, Wang Y (2024)
    Risk prediction modelling in idiopathic inflammatory myositis-associated interstitial lung disease based on seven factors including serum KL-6 and lung ultrasound B-lines
    Clin Exp Rheumatol, 43 (2), 260-268
    DOI 10.55563/clinexprheumatol/ylf0oe, PubMed 39360376
  28. Wang Y, Chen S, Zheng S, Zhou Z, Zhang W, Du G, Mikish A, Ruaro B, Bruni C, Hoffmann-Vold AM, Gargani L, Matucci-Cerinic M, Furst DE (2024)
    A versatile role for lung ultrasound in systemic autoimmune rheumatic diseases related pulmonary involvement: a narrative review
    Arthritis Res Ther, 26 (1), 164
    DOI 10.1186/s13075-024-03399-2, PubMed 39294670
  29. Kuwana M, Avouac J, Hoffmann-Vold AM, Smith V, Toenges G, Alves M, Distler O (2024)
    Development of a multivariable prediction model for progression of systemic sclerosis-associated interstitial lung disease
    RMD Open, 10 (3)
    DOI 10.1136/rmdopen-2024-004240, PubMed 39242112
  30. Ruscitti P, Allanore Y, Baldini C, Barilaro G, Bartoloni Bocci E, Bearzi P, Bellis E, Berardicurti O, Biaggi A, Bombardieri M, Cantarini L, Cantatore FP, Caporali R, Caso F, Cervera R, Ciccia F, Cipriani P, Chatzis L, Colafrancesco S, Conti F, Corberi E, Costa L, Currado D, Cutolo M, D'Angelo S et al. (2024)
    Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus
    Autoimmun Rev, 23 (7-8), 103581
    DOI 10.1016/j.autrev.2024.103581, PubMed 39069240
  31. Sparks JA, Dieudé P, Hoffmann-Vold AM, Burmester GR, Walsh SL, Kreuter M, Stock C, Sambevski S, Alves M, Emery P (2024)
    Design of ANCHOR-RA: a multi-national cross-sectional study on screening for interstitial lung disease in patients with rheumatoid arthritis
    BMC Rheumatol, 8 (1), 19
    DOI 10.1186/s41927-024-00389-4, PubMed 38773593
  32. Muraru S, Mihai C, Elhai M, Becker M, Jordan S, Garaiman A, Bruni C, Petelytska L, Hoffmann-Vold AM, Distler O, Dobrota R (2025)
    Arthritis in patients with very early systemic sclerosis: a comprehensive clinical and prognostic analysis
    Rheumatology (Oxford), 64 (3), 1243-1250
    DOI 10.1093/rheumatology/keae247, PubMed 38724227
  33. Dima A, Vonk MC, Garaiman A, Kersten BE, Becvar R, Tomcik M, Hoffmann-Vold AM, Castellvi I, Jaime JT, Brzosko M, Milchert M, Krasowska D, Michalska-Jakubus M, Airo P, Matucci-Cerinic M, Bruni C, Iudici M, Distler J, Gheorghiu AM, Poormoghim H, Motta F, De Santis M, Parvu M, Distler O, Mihai C (2024)
    Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research (EUSTAR) cohort and a systematic literature review
    Eur J Intern Med, 125, 104-110
    DOI 10.1016/j.ejim.2024.03.035, PubMed 38599922
  34. Windirsch K, Jordan S, Becker MO, Bruni C, Dobrota R, Elhai M, Garaiman IA, Mihai CM, Iudici M, Hasler P, Ribi C, Maurer B, Gabrielli A, Hoffmann-Vold AM, Distler O (2024)
    Therapeutic management of fibrosis in systemic sclerosis patients - an analysis from the Swiss EUSTAR cohort
    Swiss Med Wkly, 154, 3630
    DOI 10.57187/s.3630, PubMed 38579324
  35. Kawano-Dourado L, Kulkarni T, Ryerson CJ, Rivera-Ortega P, Baldi BG, Chaudhuri N, Funke-Chambour M, Hoffmann-Vold AM, Johannson KA, Khor YH, Montesi SB, Piccari L, Prosch H, Molina-Molina M, Sellares Torres J, Bauer-Ventura I, Rajan S, Jacob J, Richards D, Spencer LG, Wendelberger B, Jensen T, Quintana M, Kreuter M, Gordon AC et al. (2024)
    Adaptive multi-interventional trial platform to improve patient care for fibrotic interstitial lung diseases
    Thorax, 79 (8), 788-795
    DOI 10.1136/thorax-2023-221148, PubMed 38448221
  36. Lepri G, Bruni C, Tofani L, Moggi-Pignone A, Orlandi M, Tomassetti S, Hughes M, Del Galdo F, Irace R, Distler O, Riccieri V, Allanore Y, Gheorghiu AM, Siegert E, De Vries-Bouwstra J, Hachulla E, Tikly M, Damjanov N, Spertini F, Mouthon L, Hoffmann-Vold AM, Gabrielli A, Guiducci S, Matucci-Cerinic M, Furst D et al. (2024)
    The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis-Interstitial Lung Disease in the European Scleroderma Trial and Research Database
    Diagnostics (Basel), 14 (3)
    DOI 10.3390/diagnostics14030295, PubMed 38337811
  37. Provan SA, Ahlfors F, Bakland G, Hu Y, Kristianslund EK, Ikdahl E, Kvien TK, Aaløkken TM, Hoffmann-Vold AM (2024)
    A validation of register-derived diagnoses of interstitial lung disease in patients with inflammatory arthritis: data from the NOR-DMARD study
    Scand J Rheumatol, 53 (3), 173-179
    DOI 10.1080/03009742.2024.2306716, PubMed 38314728
  38. Bruni C, Tofani L, Garaiman A, Jordan S, Mihai CM, Dobrota R, Elhai M, Becker MO, Hoffmann-Vold AM, Frauenfelder T, Matucci-Cerinic M, Distler O (2024)
    Histogram-Based Densitometry Index to Assess the Severity of Interstitial Lung Disease in Systemic Sclerosis in Standard and Low-Dose Computed Tomography
    J Rheumatol, 51 (3), 270-276
    DOI 10.3899/jrheum.2023-0415, PubMed 38302169
  39. Van Epps H, Clark A, Hoffmann-Vold AM, Distler O (2022)
    Call for papers: Sex and gender in rheumatology
    Lancet Rheumatol, 4 (3), e168
    DOI 10.1016/S2665-9913(22)00036-4, PubMed 38288935
  40. Dobrota R, Jordan S, Juhl P, Maurer B, Wildi L, Bay-Jensen AC, Karsdal MA, Herrick AL, Distler JHW, Allanore Y, Hoffmann-Vold AM, Siebuhr AS, Distler O (2021)
    Circulating collagen neo-epitopes and their role in the prediction of fibrosis in patients with systemic sclerosis: a multicentre cohort study
    Lancet Rheumatol, 3 (3), e175-e184
    DOI 10.1016/S2665-9913(20)30385-4, PubMed 38279380
  41. Hoffmann-Vold AM, Maher TM, Distler O (2020)
    European consensus statements for interstitial lung disease in systemic sclerosis - Authors' reply
    Lancet Rheumatol, 2 (6), e319-e320
    DOI 10.1016/S2665-9913(20)30098-9, PubMed 38273593
  42. Hoffmann-Vold AM, Volkmann ER, Allanore Y, Assassi S, de Vries-Bouwstra JK, Smith V, Tschoepe I, Loaiza L, Kanakapura M, Distler O (2022)
    Safety and tolerability of nintedanib in patients with interstitial lung diseases in subgroups by sex: a post-hoc analysis of pooled data from four randomised controlled trials
    Lancet Rheumatol, 4 (10), e679-e687
    DOI 10.1016/S2665-9913(22)00215-6, PubMed 38265966
  43. Elhai M, Sritharan N, Boubaya M, Balbir-Gurman A, Siegert E, Hachulla E, de Vries-Bouwstra J, Riemekasten G, Distler JHW, Rosato E, Del Galdo F, Mendoza FA, Furst DE, de la Puente C, Hoffmann-Vold AM, Gabrielli A, Distler O, Bloch-Queyrat C, Allanore Y, EUSTAR collaborators (2022)
    Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort
    Lancet Rheumatol, 4 (11), e785-e794
    DOI 10.1016/S2665-9913(22)00217-X, PubMed 38265945
  44. Hoffmann-Vold AM, Maher TM, Philpot EE, Ashrafzadeh A, Barake R, Barsotti S, Bruni C, Carducci P, Carreira PE, Castellví I, Del Galdo F, Distler JHW, Foeldvari I, Fraticelli P, George PM, Griffiths B, Guillén-Del-Castillo A, Hamid AM, Horváth R, Hughes M, Kreuter M, Moazedi-Fuerst F, Olas J, Paul S, Rotondo C et al. (2020)
    The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements
    Lancet Rheumatol, 2 (2), e71-e83
    DOI 10.1016/S2665-9913(19)30144-4, PubMed 38263663
  45. Volkmann ER, Sparks JA, Hoffmann-Vold AM, Doyle TJ, Emery P, Dieudé P (2023)
    Preclinical or subclinical rheumatoid arthritis-associated interstitial lung disease: misleading terms with potentially deleterious consequences
    Lancet Rheumatol, 5 (3), e116-e118
    DOI 10.1016/S2665-9913(23)00033-4, PubMed 38251607
  46. Scheidegger M, Boubaya M, Garaiman A, Barua I, Becker M, Bjørkekjær HJ, Bruni C, Dobrota R, Fretheim H, Jordan S, Midtvedt O, Mihai C, Hoffmann-Vold AM, Distler O, Elhai M (2024)
    Characteristics and disease course of untreated patients with interstitial lung disease associated with systemic sclerosis in a real-life two-centre cohort
    RMD Open, 10 (1)
    DOI 10.1136/rmdopen-2023-003658, PubMed 38199606
  47. Gegenava T, Fortuni F, van Leeuwen NM, Tennoe AH, Hoffmann-Vold AM, Jurcut R, Giuca A, Groseanu L, Tanner F, Distler O, Bax JJ, De Vries-Bouwstra J, Ajmone Marsan N (2023)
    Sex-specific difference in cardiac function in patients with systemic sclerosis: association with cardiovascular outcomes
    RMD Open, 9 (4)
    DOI 10.1136/rmdopen-2023-003380, PubMed 37949614
  48. Guler S, Sarbu AC, Stalder O, Allanore Y, Bernardino V, Distler J, Gabrielli A, Hoffmann-Vold AM, Matucci-Cerinic M, Müller-Ladner U, Ortiz-Santamaria V, Rednic S, Riccieri V, Smith V, Ullman S, Walker UA, Geiser TK, Distler O, Maurer B, Kollert F (2023)
    Phenotyping by persistent inflammation in systemic sclerosis associated interstitial lung disease: a EUSTAR database analysis
    Thorax, 78 (12), 1188-1196
    DOI 10.1136/thorax-2023-220541, PubMed 37798114
  49. Maher TM, Assassi S, Azuma A, Cottin V, Hoffmann-Vold AM, Kreuter M, Oldham JM, Richeldi L, Valenzuela C, Wijsenbeek MS, Coeck C, Schlecker C, Voss F, Wachtlin D, Martinez FJ (2023)
    Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD)
    BMJ Open Respir Res, 10 (1)
    DOI 10.1136/bmjresp-2022-001580, PubMed 37709661
  50. Boleto G, Reiseter S, Hoffmann-Vold AM, Mirouse A, Cacoub P, Matucci-Cerinic M, Silvério-António M, Fonseca JE, Duarte AC, Pestana Lopes J, Riccieri V, Lescoat A, Le Tallec E, Castellví Barranco I, Tandaipan JL, Airó P, Kuwana M, Kavosi H, Avouac J, Allanore Y (2023)
    The phenotype of mixed connective tissue disease patients having associated interstitial lung disease
    Semin Arthritis Rheum, 63, 152258
    DOI 10.1016/j.semarthrit.2023.152258, PubMed 37696231
  51. Vikse J, Midtvedt Ø, Fevang BS, Garen T, Palm Ø, Wallenius M, Bakland G, Norheim KB, Molberg Ø, Hoffmann-Vold AM (2023)
    Differential sensitivity of the 2020 revised comprehensive diagnostic criteria and the 2019 ACR/EULAR classification criteria across IgG4-related disease phenotypes: results from a Norwegian cohort
    Arthritis Res Ther, 25 (1), 163
    DOI 10.1186/s13075-023-03155-y, PubMed 37670401
  52. Deibel E, Carreira PE, Vonk M, Del Papa N, Bečvář R, Guillén-Del-Castillo A, Campochiaro C, Poormoghim H, Liem S, Lazzaroni MG, Giollo A, Mekinian A, de Vries-Bouwstra J, De Santis M, Balbir-Gurman A, Mihai C, De Luca G, Moiseev S, Zanatta E, Foti R, Rednic S, Denton C, Cutolo M, Belloli L, Airo P et al. (2023)
    Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?
    Arthritis Care Res (Hoboken), 76 (1), 88-97
    DOI 10.1002/acr.25226, PubMed 37667424
  53. Lescoat A, Huang S, Carreira PE, Siegert E, de Vries-Bouwstra J, Distler JHW, Smith V, Del Galdo F, Anic B, Damjanov N, Rednic S, Ribi C, Bancel DF, Hoffmann-Vold AM, Gabrielli A, Distler O, Khanna D, Allanore Y, EUSTAR collaborators (2023)
    Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database
    JAMA Dermatol, 159 (8), 837-847
    DOI 10.1001/jamadermatol.2023.1729, PubMed 37378994
  54. Nordberg LB, Vikse J, Heiberg MS, Lillejordet E, Mæhlen MT, Kristianslund EK, Provan SA, Lillegraven S (2023)
    Rheumatology congresses post COVID-19: we cannot regress
    Lancet Rheumatol, 5 (7), e370-e371
    DOI 10.1016/S2665-9913(23)00153-4, PubMed 37360002
  55. Allanore Y, Khanna D, Smith V, Aringer M, Hoffmann-Vold AM, Kuwana M, Merkel PA, Stock C, Sambevski S, Denton CP, SENSCIS Trial Investigators (2024)
    Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung disease
    Rheumatology (Oxford), 63 (3), 639-647
    DOI 10.1093/rheumatology/kead280, PubMed 37294870
  56. Jones S, Flewett M, Flewett R, Lee S, Vick B, Thompson M, Pinnetti S, Zoz DF, Hoffmann-Vold AM, Kreuter M, Maher TM (2023)
    Clinical trial simulations in pulmonary fibrosis: patient-focused insights and adaptations
    ERJ Open Res, 9 (3)
    DOI 10.1183/23120541.00602-2022, PubMed 37260456
  57. Vonk MC, Assassi S, Hoffmann-Vold AM (2023)
    Scleroderma Skin: How Is Treatment Best Guided by Data and Implemented in Clinical Practice?
    Rheum Dis Clin North Am, 49 (2), 249-262
    DOI 10.1016/j.rdc.2023.01.003, PubMed 37028833
  58. Khanna D, Maher TM, Volkmann ER, Allanore Y, Smith V, Assassi S, Kreuter M, Hoffmann-Vold AM, Kuwana M, Stock C, Alves M, Sambevski S, Denton CP (2023)
    Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression
    RMD Open, 9 (1)
    DOI 10.1136/rmdopen-2022-002859, PubMed 36796874
  59. Colalillo A, Hoffmann-Vold AM, Pellicano C, Romaniello A, Gabrielli A, Hachulla E, Smith V, Simeón-Aznar CP, Castellví I, Airò P, Truchetet ME, Siegert E, Distler O, Rosato E, EUSTAR collaborators (2023)
    The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort
    Autoimmun Rev, 22 (4), 103290
    DOI 10.1016/j.autrev.2023.103290, PubMed 36746368
  60. Nakshbandi G, Moor CC, Antoniou K, Cottin V, Hoffmann-Vold AM, Koemans EA, Kreuter M, Molyneaux PL, Wuyts WA, Wijsenbeek MS (2023)
    Study protocol of an international patient-led registry in patients with pulmonary fibrosis using online home monitoring: I-FILE
    BMC Pulm Med, 23 (1), 51
    DOI 10.1186/s12890-023-02336-4, PubMed 36732734
  61. Volkmann ER, Hoffmann-Vold AM, Chang YL, Lagishetty V, Clements PJ, Midtvedt Ø, Molberg Ø, Braun J, Jacobs JP (2020)
    Longitudinal Characterisation of the Gastrointestinal Tract Microbiome in Systemic Sclerosis
    Eur Med J (Chelmsf), 7, 110-118
    DOI 10.33590/emj/20-00043, PubMed 36711108
  62. Strahm N, Didriksen H, Fretheim H, Molberg Ø, Midtvedt Ø, Farstad IN, Midtvedt T, Lundin KEA, Aabakken L, Błyszczuk P, Distler O, Kania G, Hoffmann-Vold AM (2023)
    Effects of faecal microbiota transplantation on the small intestinal mucosa in systemic sclerosis
    Rheumatology (Oxford), 62 (8), 2918-2929
    DOI 10.1093/rheumatology/kead014, PubMed 36688692
  63. Wang Y, Xie X, Zheng S, Du G, Chen S, Zhang W, Zhuang J, Lin J, Hu S, Zheng K, Mikish A, Xu Z, Zhang G, Gargani L, Bruni C, Hoffmann-Vold AM, Matucci-Cerinic M, Furst DE (2022)
    Serum B-cell activating factor and lung ultrasound B-lines in connective tissue disease related interstitial lung disease
    Front Med (Lausanne), 9, 1066111
    DOI 10.3389/fmed.2022.1066111, PubMed 36590969
  64. Campochiaro C, Hoffmann-Vold AM, Avouac J, Henes J, de Vries-Bouwstra J, Smith V, Siegert E, Airò P, Oksel F, Pellerito R, Vanthuyne M, Pozzi MR, Inanc M, Sibilia J, Gabrielli A, Distler O, Allanore Y, EUSTAR Collaborators (2023)
    Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: a EUSTAR database analysis
    Rheumatology (Oxford), 62 (7), 2483-2491
    DOI 10.1093/rheumatology/keac660, PubMed 36413079
  65. Kuster S, Jordan S, Elhai M, Held U, Steigmiller K, Bruni C, Cacciapaglia F, Vettori S, Siegert E, Rednic S, Codullo V, Airo P, Braun-Moscovici Y, Hunzelmann N, Joao Salvador M, Riccieri V, Gheorghiu AM, Alegre Sancho JJ, Romanowska-Prochnicka K, Castellví I, Kötter I, Truchetet ME, López-Longo FJ, Novikov PI, Giollo A et al. (2022)
    Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort
    RMD Open, 8 (2)
    DOI 10.1136/rmdopen-2022-002477, PubMed 36328401
  66. Hoffmann-Vold AM, Brunborg C, Airò P, Ananyeva LP, Czirják L, Guiducci S, Hachulla E, Li M, Mihai C, Riemekasten G, Sfikakis PP, Valentini G, Kowal-Bielecka O, Allanore Y, Distler O, EUSTAR collaborators (2022)
    Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research
    Chest, 163 (3), 586-598
    DOI 10.1016/j.chest.2022.09.044, PubMed 36244404
  67. Lescoat A, Huscher D, Schoof N, Airò P, de Vries-Bouwstra J, Riemekasten G, Hachulla E, Doria A, Rosato E, Hunzelmann N, Montecucco C, Gabrielli A, Hoffmann-Vold AM, Distler O, Ben Shimol J, Cutolo M, Allanore Y, (2023)
    Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region
    Rheumatology (Oxford), 62 (6), 2178-2188
    DOI 10.1093/rheumatology/keac576, PubMed 36222557
  68. Didriksen H, Molberg Ø, Mehta A, Jordan S, Palchevskiy V, Fretheim H, Gude E, Ueland T, Brunborg C, Garen T, Midtvedt Ø, Andreassen AK, Lund-Johansen F, Distler O, Belperio J, Hoffmann-Vold AM (2022)
    Target organ expression and biomarker characterization of chemokine CCL21 in systemic sclerosis associated pulmonary arterial hypertension
    Front Immunol, 13, 991743
    DOI 10.3389/fimmu.2022.991743, PubMed 36211384
  69. Roofeh D, Brown KK, Kazerooni EA, Tashkin D, Assassi S, Martinez F, Wells AU, Raghu G, Denton CP, Chung L, Hoffmann-Vold AM, Distler O, Johannson KA, Allanore Y, Matteson EL, Kawano-Dourado L, Pauling JD, Seibold JR, Volkmann ER, Walsh SLF, Oddis CV, White ES, Barratt SL, Bernstein EJ, Domsic RT et al. (2023)
    Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease
    Rheumatology (Oxford), 62 (5), 1877-1886
    DOI 10.1093/rheumatology/keac557, PubMed 36173318
  70. Iudici M, Mongin D, Siegert E, Carreira PE, Distler J, Henes J, Zanatta E, Hachulla E, De Luca G, de Souza Müller C, Santiago T, Tandaipan JL, Valdetaro Bianchi B, De Santis M, Hoffmann-Vold AM, Gabrielli A, Distler O, Courvoisier DS, EUSTAR collaborators (2023)
    Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database
    Rheumatology (Oxford), 62 (4), 1559-1567
    DOI 10.1093/rheumatology/keac533, PubMed 36099040
  71. Garaiman A, Steigmiller K, Gebhard C, Mihai C, Dobrota R, Bruni C, Matucci-Cerinic M, Henes J, de Vries-Bouwstra J, Smith V, Doria A, Allanore Y, Dagna L, Anić B, Montecucco C, Kowal-Bielecka O, Martin M, Tanaka Y, Hoffmann-Vold AM, Held U, Distler O, Becker MO, EUSTAR Collaborators (2023)
    Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model
    Rheumatology (Oxford), 62 (SI), SI91-SI100
    DOI 10.1093/rheumatology/keac405, PubMed 35904554
  72. Hoffmann-Vold AM, Distler O, Bruni C, Denton CP, de Vries-Bouwstra J, Matucci Cerinic M, Vonk MC, Gabrielli A (2022)
    Systemic sclerosis in the time of COVID-19
    Lancet Rheumatol, 4 (8), e566-e575
    DOI 10.1016/S2665-9913(22)00130-8, PubMed 35891634
  73. Hoffmann-Vold AM, Distler O, Crestani B, Antoniou KM (2022)
    Recent advances in the management of systemic sclerosis-associated interstitial lung disease
    Curr Opin Pulm Med, 28 (5), 441-447
    DOI 10.1097/MCP.0000000000000901, PubMed 35855572
  74. Bruni C, Chung L, Hoffmann-Vold AM, Assassi S, Gabrielli A, Khanna D, Bernstein EJ, Distler O, EUSTAR and SCTC collaborators (2022)
    High-resolution computed tomography of the chest for the screening, re-screening and follow-up of systemic sclerosis-associated interstitial lung disease: a EUSTAR-SCTC survey
    Clin Exp Rheumatol, 40 (10), 1951-1955
    DOI 10.55563/clinexprheumatol/7ry6zz, PubMed 35819810
  75. Hughes M, Huang S, Alegre-Sancho JJ, Carreira PE, Engelhart M, Hachulla E, Henes J, Kerzberg E, Pozzi MR, Riemekasten G, Smith V, Szücs G, Vanthuyne M, Zanatta E, Distler O, Gabrielli AG, Hoffmann-Vold AM, Steen VD, Khanna D, EUSTAR Collaborators (2023)
    Late skin fibrosis in systemic sclerosis: a study from the EUSTAR cohort
    Rheumatology (Oxford), 62 (SI), SI54-SI63
    DOI 10.1093/rheumatology/keac363, PubMed 35731139
  76. Kreuter M, Hoffmann-Vold AM, Matucci-Cerinic M, Saketkoo LA, Highland KB, Wilson H, Alves M, Erhardt E, Schoof N, Maher TM (2023)
    Impact of lung function and baseline clinical characteristics on patient-reported outcome measures in systemic sclerosis-associated interstitial lung disease
    Rheumatology (Oxford), 62 (SI), SI43-SI53
    DOI 10.1093/rheumatology/keac325, PubMed 35640959
  77. Henry B, Benoit S, Vikse J, Favaloro E, Benoit J, Lippi G (2022)
    Anti-Endothelial Cell Antibodies are not frequently elevated in hospitalized patients with COVID-19
    Acta Biomed, 93 (2), e2022043
    DOI 10.23750/abm.v93i2.11196, PubMed 35546028
  78. Lemmers JM, Fretheim H, Knaapen HK, van den Hoogen FH, van Haren-Willems JH, Duijnhouwer AL, van Dijk AP, van den Ende CH, Hoffmann-Vold AM, Vonk MC (2020)
    Selexipag treatment in patients with systemic sclerosis-associated pulmonary arterial hypertension in clinical practice, a case series
    J Scleroderma Relat Disord, 5 (3), NP7-NP11
    DOI 10.1177/2397198320916082, PubMed 35382522
  79. Hoffmann-Vold AM, Volkmann ER (2019)
    Gastrointestinal involvement in systemic sclerosis: Effects on morbidity and mortality and new therapeutic approaches
    J Scleroderma Relat Disord, 6 (1), 37-43
    DOI 10.1177/2397198319891282, PubMed 35382247
  80. Hoffmann-Vold AM, Fretheim H, Meier C, Maurer B (2020)
    Circulating biomarkers of systemic sclerosis - interstitial lung disease
    J Scleroderma Relat Disord, 5 (2 Suppl), 41-47
    DOI 10.1177/2397198319894851, PubMed 35382223
  81. Zanatta E, Huscher D, Ortolan A, Avouac J, Airò P, Balbir-Gurman A, Siegert E, Matucci Cerinic M, Cozzi F, Riemekasten G, Hoffmann-Vold AM, Distler O, Gabrielli A, Heitmann S, Hunzelmann N, Montecucco C, Morovic-Vergles J, Ribi C, Doria A, Allanore Y, EUSTAR collaborators (2022)
    Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort
    Rheumatology (Oxford), 61 (12), 4786-4796
    DOI 10.1093/rheumatology/keac188, PubMed 35348643
  82. Henry BM, Benoit S, Vikse J, Favaloro E, Benoit J, Lippi G (2022)
    Anti-Endothelial Cell Antibodies are not frequently elevated in hospitalized patients with COVID-19
    Acta Biomed, 93 (1), e2022026
    DOI 10.23750/abm.v93i1.10799, PubMed 35315426
  83. Mutua V, Henry BM, Csefalvay CV, Cheruiyot I, Vikse J, Lippi G, Bundi B, Mong'are N (2022)
    Tocilizumab in addition to standard of care in the management of COVID-19: a meta-analysis of RCTs
    Acta Biomed, 93 (1), e2022014
    DOI 10.23750/abm.v93i1.12208, PubMed 35315395
  84. Tennøe AH, Murbræch K, Didriksen H, Ueland T, Palchevskiy V, Weigt SS, Fretheim H, Midtvedt Ø, Garen T, Brunborg C, Aukrust P, Molberg Ø, Belperio JA, Hoffmann-Vold AM (2022)
    Serum markers of cardiac complications in a systemic sclerosis cohort
    Sci Rep, 12 (1), 4661
    DOI 10.1038/s41598-022-08815-8, PubMed 35304587
  85. van Leeuwen NM, Boonstra M, Fretheim H, Brunborg C, Midtvedt Ø, Garen T, Molberg Ø, Huizinga TWJ, de Vries-Bouwstra JK, Hoffman-Vold AM (2022)
    Gastrointestinal symptom severity and progression in systemic sclerosis
    Rheumatology (Oxford), 61 (10), 4024-4034
    DOI 10.1093/rheumatology/keac118, PubMed 35238377
  86. Bruni C, Heidenreich S, Duenas A, Hoffmann-Vold AM, Gabrielli A, Allanore Y, Chatelus E, Distler JHW, Hachulla E, Hsu VM, Hunzelmann N, Khanna D, Truchetet ME, Walker UA, Alves M, Schoof N, Saketkoo LA, Distler O (2022)
    Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experiment
    Rheumatology (Oxford), 61 (10), 4035-4046
    DOI 10.1093/rheumatology/keac126, PubMed 35238334
  87. Matteson EL, Kelly C, Distler JHW, Hoffmann-Vold AM, Seibold JR, Mittoo S, Dellaripa PF, Aringer M, Pope J, Distler O, James A, Schlenker-Herceg R, Stowasser S, Quaresma M, Flaherty KR, INBUILD Trial Investigators (2022)
    Nintedanib in Patients With Autoimmune Disease-Related Progressive Fibrosing Interstitial Lung Diseases: Subgroup Analysis of the INBUILD Trial
    Arthritis Rheumatol, 74 (6), 1039-1047
    DOI 10.1002/art.42075, PubMed 35199968
  88. Volkmann ER, Kreuter M, Hoffmann-Vold AM, Wijsenbeek M, Smith V, Khanna D, Denton CP, Wuyts WA, Miede C, Alves M, Sambevski S, Allanore Y (2022)
    Dyspnoea and cough in patients with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial
    Rheumatology (Oxford), 61 (11), 4397-4408
    DOI 10.1093/rheumatology/keac091, PubMed 35150246
  89. Hilberg O, Hoffmann-Vold AM, Smith V, Bouros D, Kilpeläinen M, Guiot J, Morais A, Clemente S, Daniil Z, Papakosta D, Fretheim H, Neves S, Alfaro TM, Antoniou KM, Valveny N, Asijee G, Soulard S, Wuyts W (2022)
    Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries
    ERJ Open Res, 8 (1)
    DOI 10.1183/23120541.00597-2021, PubMed 35083316
  90. Schniering J, Maciukiewicz M, Gabrys HS, Brunner M, Blüthgen C, Meier C, Braga-Lagache S, Uldry AC, Heller M, Guckenberger M, Fretheim H, Nakas CT, Hoffmann-Vold AM, Distler O, Frauenfelder T, Tanadini-Lang S, Maurer B (2022)
    Computed tomography-based radiomics decodes prognostic and molecular differences in interstitial lung disease related to systemic sclerosis
    Eur Respir J, 59 (5)
    DOI 10.1183/13993003.04503-2020, PubMed 34649979
  91. Buschulte K, Hoffmann-Vold AM, Dobrota RD, Höger P, Krause A, Kreuter M (2021)
    [Treatment of lung fibrosis in systemic rheumatic diseases (new treatment)]
    Z Rheumatol, 80 (8), 743-754
    DOI 10.1007/s00393-021-01067-3, PubMed 34505934
  92. Kreuter M, Hoffmann-Vold AM, Bendstrup E (2021)
    Interstitial lung diseases: quo vadis?
    Lancet Respir Med, 9 (10), 1084-1087
    DOI 10.1016/S2213-2600(21)00403-3, PubMed 34499873
  93. Panagopoulos P, Goules A, Hoffmann-Vold AM, Matteson EL, Tzioufas A (2021)
    Natural history and screening of interstitial lung disease in systemic autoimmune rheumatic disorders
    Ther Adv Musculoskelet Dis, 13, 1759720X211037519
    DOI 10.1177/1759720X211037519, PubMed 34471427
  94. Hoffmann-Vold AM, Kreuter M (2021)
    One-step closer to solve the mystery of predicting disease progression in systemic sclerosis associated interstitial lung disease?
    Thorax, 76 (12), 1170-1171
    DOI 10.1136/thoraxjnl-2021-217811, PubMed 34446525
  95. Wang Y, Chen S, Zheng S, Lin J, Hu S, Zhuang J, Lin Q, Xie X, Zheng K, Zhang W, Du G, Zhang G, Hoffmann-Vold AM, Matucci-Cerinic M, Furst DE (2021)
    The role of lung ultrasound B-lines and serum KL-6 in the screening and follow-up of rheumatoid arthritis patients for an identification of interstitial lung disease: review of the literature, proposal for a preliminary algorithm, and clinical application to cases
    Arthritis Res Ther, 23 (1), 212
    DOI 10.1186/s13075-021-02586-9, PubMed 34391465
  96. Henry BM, Benscoter AL, de Oliveira MHS, Vikse J, Perry T, Cooper DS (2021)
    Outcomes of extracorporeal life support for respiratory failure in children with primary immunodeficiencies
    Perfusion, 38 (1), 37-43
    DOI 10.1177/02676591211033946, PubMed 34278883
  97. Solomon JJ, Swigris JJ, Kreuter M, Polke M, Aronson K, Hoffmann-Vold AM, Dellaripa PF (2022)
    The attitudes and practices of physicians caring for patients with rheumatoid arthritis-associated interstitial lung disease: an international survey
    Rheumatology (Oxford), 61 (4), 1459-1467
    DOI 10.1093/rheumatology/keab552, PubMed 34260687
  98. Hoffmann-Vold AM, Fretheim HH, Sarna VK, Barua I, Carstens MN, Distler O, Khanna D, Volkmann ER, Midtvedt Ø, Didriksen H, Dhainaut A, Halse AK, Bakland G, Pesonen M, Olsen I, Molberg Ø (2021)
    Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: study protocol for the randomised controlled phase II ReSScue trial
    BMJ Open, 11 (6), e048541
    DOI 10.1136/bmjopen-2020-048541, PubMed 34168032
  99. van Leeuwen NM, Boonstra M, Bakker JA, Grummels A, Jordan S, Liem S, Distler O, Hoffmann-Vold AM, Melsens K, Smith V, Truchetet ME, Scherer HU, Toes R, Huizinga TWJ, de Vries-Bouwstra JK (2021)
    Anticentromere Antibody Levels and Isotypes and the Development of Systemic Sclerosis
    Arthritis Rheumatol, 73 (12), 2338-2347
    DOI 10.1002/art.41814, PubMed 34042326
  100. Iudici M, Jarlborg M, Lauper K, Müller-Ladner U, Smith V, Allanore Y, Balbir-Gurman A, Doria A, Airò P, Walker UA, Riccieri V, Vonk MC, Gabrielli A, Hoffmann-Vold AM, Szücs G, Martin T, Distler O, Courvoisier DS, EUSTAR collaborators (2022)
    Representativeness of systemic sclerosis patients in interventional randomized trials: an analysis of the EUSTAR database
    Rheumatology (Oxford), 61 (2), 743-755
    DOI 10.1093/rheumatology/keab437, PubMed 33989387
  101. Henry BM, Szergyuk I, de Oliveira MHS, Lippi G, Benoit JL, Vikse J, Benoit SW (2021)
    Complement levels at admission as a reflection of coronavirus disease 2019 (COVID-19) severity state
    J Med Virol, 93 (9), 5515-5522
    DOI 10.1002/jmv.27077, PubMed 33974276
  102. Gigante A, Hoffmann-Vold AM, Alunni Fegatelli D, Gabrielli A, Leodori G, Coleiro B, De Santis M, Dagna L, Alegre-Sancho JJ, Montecucco C, Carreira PE, Balbir-Gurman A, Doria A, Riemekasten G, Airò P, Distler J, Distler O, Rosato E, EUSTAR collaborators (2021)
    Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database
    Rheumatology (Oxford), 61 (1), 213-222
    DOI 10.1093/rheumatology/keab302, PubMed 33769468
  103. Hoffmann-Vold AM, Maher TM, Philpot EE, Ashrafzadeh A, Distler O (2021)
    Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic review
    ERJ Open Res, 7 (1)
    DOI 10.1183/23120541.00235-2020, PubMed 33644224
  104. Hoffmann-Vold AM, Bendstrup E, Dimitroulas T, Hesselstrand R, Morais A, Peltomaa R, Smith V, Welling J, Vonk MC, Wuyts WA (2021)
    Identifying unmet needs in SSc-ILD by semi-qualitative in-depth interviews
    Rheumatology (Oxford), 60 (12), 5601-5609
    DOI 10.1093/rheumatology/keab154, PubMed 33587103
  105. Henry BM, Benoit SW, Vikse J, Berger BA, Pulvino C, Hoehn J, Rose J, Santos de Oliveira MH, Lippi G, Benoit JL (2020)
    The anti-inflammatory cytokine response characterized by elevated interleukin-10 is a stronger predictor of severe disease and poor outcomes than the pro-inflammatory cytokine response in coronavirus disease 2019 (COVID-19)
    Clin Chem Lab Med, 59 (3), 599-607
    DOI 10.1515/cclm-2020-1284, PubMed 33554561
  106. Didriksen H, Molberg Ø, Fretheim H, Gude E, Jordan S, Brunborg C, Palchevskiy V, Garen T, Midtvedt Ø, Andreassen AK, Distler O, Belperio J, Hoffmann-Vold AM (2021)
    Association of Lymphangiogenic Factors With Pulmonary Arterial Hypertension in Systemic Sclerosis
    Arthritis Rheumatol, 73 (7), 1277-1287
    DOI 10.1002/art.41665, PubMed 33497027
  107. Highland KB, Distler O, Kuwana M, Allanore Y, Assassi S, Azuma A, Bourdin A, Denton CP, Distler JHW, Hoffmann-Vold AM, Khanna D, Mayes MD, Raghu G, Vonk MC, Gahlemann M, Clerisme-Beaty E, Girard M, Stowasser S, Zoz D, Maher TM, SENSCIS trial investigators (2021)
    Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial
    Lancet Respir Med, 9 (1), 96-106
    DOI 10.1016/S2213-2600(20)30330-1, PubMed 33412120
  108. Olson A, Hartmann N, Patnaik P, Wallace L, Schlenker-Herceg R, Nasser M, Richeldi L, Hoffmann-Vold AM, Cottin V (2020)
    Estimation of the Prevalence of Progressive Fibrosing Interstitial Lung Diseases: Systematic Literature Review and Data from a Physician Survey
    Adv Ther, 38 (2), 854-867
    DOI 10.1007/s12325-020-01578-6, PubMed 33315170
  109. Benvenuti F, Zanatta E, Avouac J, Müller-Ladner U, Cozzi F, Hoffmann-Vold AM, Gabrielli A, Distler O, Matucci-Cerinic M, Allanore Y, Doria A (2020)
    The power of the EUSTAR cohort: key findings to date and implications for management of systemic sclerosis patients
    Expert Rev Clin Immunol, 16 (11), 1065-1074
    DOI 10.1080/1744666X.2021.1836962, PubMed 33076716
  110. Spagnolo P, Distler O, Ryerson CJ, Tzouvelekis A, Lee JS, Bonella F, Bouros D, Hoffmann-Vold AM, Crestani B, Matteson EL (2020)
    Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)
    Ann Rheum Dis, 80 (2), 143-150
    DOI 10.1136/annrheumdis-2020-217230, PubMed 33037004
  111. Hoffmann-Vold AM, Allanore Y, Alves M, Brunborg C, Airó P, Ananieva LP, Czirják L, Guiducci S, Hachulla E, Li M, Mihai C, Riemekasten G, Sfikakis PP, Kowal-Bielecka O, Riccardi A, Distler O, EUSTAR collaborators (2020)
    Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database
    Ann Rheum Dis, 80 (2), 219-227
    DOI 10.1136/annrheumdis-2020-217455, PubMed 32988845
  112. Henry B, Cheruiyot I, Vikse J, Mutua V, Kipkorir V, Benoit J, Plebani M, Bragazzi N, Lippi G (2020)
    Lymphopenia and neutrophilia at admission predicts severity and mortality in patients with COVID-19: a meta-analysis
    Acta Biomed, 91 (3), e2020008
    DOI 10.23750/abm.v91i3.10217, PubMed 32921706
  113. Hoffmann-Vold AM, Molberg Ø (2020)
    Detection, screening, and classification of interstitial lung disease in patients with systemic sclerosis
    Curr Opin Rheumatol, 32 (6), 497-504
    DOI 10.1097/BOR.0000000000000741, PubMed 32890027
  114. Henry BM, Aggarwal G, Wong J, Benoit S, Vikse J, Plebani M, Lippi G (2020)
    Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis
    Am J Emerg Med, 38 (9), 1722-1726
    DOI 10.1016/j.ajem.2020.05.073, PubMed 32738466
  115. Hoffmann-Vold AM, Allanore Y, Bendstrup E, Bruni C, Distler O, Maher TM, Wijsenbeek M, Kreuter M (2020)
    The need for a holistic approach for SSc-ILD - achievements and ambiguity in a devastating disease
    Respir Res, 21 (1), 197
    DOI 10.1186/s12931-020-01459-0, PubMed 32703199
  116. Durheim MT, Hoffmann-Vold AM, Eagan TM, Hovden AO, Lund MB, Bjerke G, Birring SS, Jonassen TM, Johansen OE, Sjåheim T (2020)
    ILD-specific health-related quality of life in systemic sclerosis-associated ILD compared with IPF
    BMJ Open Respir Res, 7 (1)
    DOI 10.1136/bmjresp-2020-000598, PubMed 32576559
  117. Vikse J, Lippi G, Henry BM (2020)
    Do sex-specific immunobiological factors and differences in angiotensin converting enzyme 2 (ACE2) expression explain increased severity and mortality of COVID-19 in males?
    Diagnosis (Berl), 7 (4), 385-386
    DOI 10.1515/dx-2020-0054, PubMed 32549125
  118. Fretheim H, Chung BK, Didriksen H, Bækkevold ES, Midtvedt Ø, Brunborg C, Holm K, Valeur J, Tennøe AH, Garen T, Midtvedt T, Trøseid M, Zarè H, Lund MB, Hov JR, Lundin KEA, Molberg Ø, Hoffmann-Vold AM (2020)
    Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial
    PLoS One, 15 (5), e0232739
    DOI 10.1371/journal.pone.0232739, PubMed 32437393
  119. Vikse J, Henry BM (2020)
    Tocilizumab in COVID-19: Beware the risk of intestinal perforation
    Int J Antimicrob Agents, 56 (1), 106009
    DOI 10.1016/j.ijantimicag.2020.106009, PubMed 32389721
  120. Henry BM, Vikse J, Benoit S, Favaloro EJ, Lippi G (2020)
    Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis
    Clin Chim Acta, 507, 167-173
    DOI 10.1016/j.cca.2020.04.027, PubMed 32348783
  121. Pękala PA, Henry BM, Pękala JR, Hsieh WC, Vikse J, Sanna B, Walocha JA, Tubbs SR, Tomaszewski KA (2017)
    Prevalence of foramen arcuale and its clinical significance: A meta-analysis of 55,985 subjects: <b>PS095</b>
    Porto Biomed J, 2 (5), 190
    DOI 10.1016/j.pbj.2017.07.036, PubMed 32258648
  122. Henry BM, Vikse J (2020)
    Clinical Characteristics of Covid-19 in China
    N Engl J Med, 382 (19), 1860-1861
    DOI 10.1056/NEJMc2005203, PubMed 32220205
  123. Fretheim H, Halse AK, Seip M, Bitter H, Wallenius M, Garen T, Salberg A, Brunborg C, Midtvedt Ø, Molberg Ø, Hoffmann-Vold AM (2020)
    Multidimensional tracking of phenotypes and organ involvement in a complete nationwide systemic sclerosis cohort
    Rheumatology (Oxford), 59 (10), 2920-2929
    DOI 10.1093/rheumatology/keaa026, PubMed 32097470
  124. Distler O, Assassi S, Cottin V, Cutolo M, Danoff SK, Denton CP, Distler JHW, Hoffmann-Vold AM, Johnson SR, Müller Ladner U, Smith V, Volkmann ER, Maher TM (2020)
    Predictors of progression in systemic sclerosis patients with interstitial lung disease
    Eur Respir J, 55 (5)
    DOI 10.1183/13993003.02026-2019, PubMed 32079645
  125. Volkmann ER, Hoffmann-Vold AM (2019)
    Gastrointestinal tract microbiota modifications in systemic sclerosis
    Eur J Rheumatol, 7 (Suppl 3), S228-S236
    DOI 10.5152/eurjrheum.2019.19103, PubMed 31922474
  126. Hoffmann-Vold AM, Fretheim H, Didriksen H, Molberg Ø (2020)
    The potential of fecal microbiota transplantation in systemic sclerosis
    Expert Rev Clin Immunol, 16 (2), 117-118
    DOI 10.1080/1744666X.2019.1707665, PubMed 31858856
  127. Tennøe AH, Murbræch K, Andreassen JC, Fretheim H, Midtvedt Ø, Garen T, Dalen H, Gude E, Andreassen A, Aakhus S, Molberg Ø, Hoffmann-Vold AM (2019)
    Systolic Dysfunction in Systemic Sclerosis: Prevalence and Prognostic Implications
    ACR Open Rheumatol, 1 (4), 258-266
    DOI 10.1002/acr2.1037, PubMed 31777802
  128. Hoffmann-Vold AM, Weigt SS, Saggar R, Palchevskiy V, Volkmann ER, Liang LL, Ross D, Ardehali A, Lynch JP, Belperio JA (2019)
    Endotype-phenotyping may predict a treatment response in progressive fibrosing interstitial lung disease
    EBioMedicine, 50, 379-386
    DOI 10.1016/j.ebiom.2019.10.050, PubMed 31732480
  129. López-Isac E, Acosta-Herrera M, Kerick M, Assassi S, Satpathy AT, Granja J, Mumbach MR, Beretta L, Simeón CP, Carreira P, Ortego-Centeno N, Castellvi I, Bossini-Castillo L, Carmona FD, Orozco G, Hunzelmann N, Distler JHW, Franke A, Lunardi C, Moroncini G, Gabrielli A, de Vries-Bouwstra J, Wijmenga C, Koeleman BPC, Nordin A et al. (2019)
    GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
    Nat Commun, 10 (1), 4955
    DOI 10.1038/s41467-019-12760-y, PubMed 31672989
  130. Distler O, Volkmann ER, Hoffmann-Vold AM, Maher TM (2019)
    Current and future perspectives on management of systemic sclerosis-associated interstitial lung disease
    Expert Rev Clin Immunol, 15 (10), 1009-1017
    DOI 10.1080/1744666X.2020.1668269, PubMed 31566449
  131. Kreuter M, Hoffmann-Vold AM (2019)
    [New ways in the treatment of SSc-ILD: what makes sense?]
    Z Rheumatol, 78 (9), 863-864
    DOI 10.1007/s00393-019-00704-2, PubMed 31485729
  132. Hoffmann-Vold AM, Fretheim H, Halse AK, Seip M, Bitter H, Wallenius M, Garen T, Salberg A, Brunborg C, Midtvedt Ø, Lund MB, Aaløkken TM, Molberg Ø (2019)
    Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort
    Am J Respir Crit Care Med, 200 (10), 1258-1266
    DOI 10.1164/rccm.201903-0486OC, PubMed 31310156
  133. Elhai M, Hoffmann-Vold AM, Allanore Y (2019)
    Reply
    Arthritis Rheumatol, 71 (7), 1204-1206
    DOI 10.1002/art.40908, PubMed 31082000
  134. Vikse J, Johnsen SJA, Rønning B, Wildhagen K, Bryne K, Omdal R (2019)
    [Tubulointerstitial nephritis and uveitis syndrome]
    Tidsskr Nor Laegeforen, 139 (8)
    DOI 10.4045/tidsskr.18.0840, PubMed 31062556
  135. Hoffmann-Vold AM, Distler O, Murray B, Kowal-Bielecka O, Khanna D, Allanore Y, EUSTAR and SCTC collaborators (2019)
    Setting the international standard for longitudinal follow-up of patients with systemic sclerosis: a Delphi-based expert consensus on core clinical features
    RMD Open, 5 (1), e000826
    DOI 10.1136/rmdopen-2018-000826, PubMed 30997150
  136. Elhai M, Boubaya M, Distler O, Smith V, Matucci-Cerinic M, Alegre Sancho JJ, Truchetet ME, Braun-Moscovici Y, Iannone F, Novikov PI, Lescoat A, Siegert E, Castellví I, Airó P, Vettori S, De Langhe E, Hachulla E, Erler A, Ananieva L, Krusche M, López-Longo FJ, Distler JHW, Hunzelmann N, Hoffmann-Vold AM, Riccieri V et al. (2019)
    Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study
    Ann Rheum Dis, 78 (7), 979-987
    DOI 10.1136/annrheumdis-2018-214816, PubMed 30967395
  137. Vikse J, Jonsdottir K, Kvaløy JT, Wildhagen K, Omdal R (2019)
    Tolerability and safety of long-term rituximab treatment in systemic inflammatory and autoimmune diseases
    Rheumatol Int, 39 (6), 1083-1090
    DOI 10.1007/s00296-019-04272-1, PubMed 30923955
  138. Vikse J, Sæverås MZ, Staal EM, Gøransson LG (2019)
    [Purple urine bag syndrome]
    Tidsskr Nor Laegeforen, 139 (6)
    DOI 10.4045/tidsskr.18.0677, PubMed 30917642
  139. Vikse J, Omdal R (2019)
    Fatigue in Mastocytosis: A Case Series
    Clin Ther, 41 (4), 625-632
    DOI 10.1016/j.clinthera.2019.01.016, PubMed 30797624
  140. Volkmann ER, Tashkin DP, Sim M, Li N, Khanna D, Roth MD, Clements PJ, Hoffmann-Vold AM, Furst DE, Kim G, Goldin J, Elashoff RM (2019)
    Cyclophosphamide for Systemic Sclerosis-related Interstitial Lung Disease: A Comparison of Scleroderma Lung Study I and II
    J Rheumatol, 46 (10), 1316-1325
    DOI 10.3899/jrheum.180441, PubMed 30770517
  141. Taterra D, Wong LM, Vikse J, Sanna B, Pękala P, Walocha J, Cirocchi R, Tomaszewski K, Henry BM (2019)
    The prevalence and anatomy of parathyroid glands: a meta-analysis with implications for parathyroid surgery
    Langenbecks Arch Surg, 404 (1), 63-70
    DOI 10.1007/s00423-019-01751-8, PubMed 30762091
  142. Vikse J, Sæland C, Ogne C, Greve OJ, Johnsen SJA (2019)
    [Coronary artery aneurysms]
    Tidsskr Nor Laegeforen, 139 (2)
    DOI 10.4045/tidsskr.18.0325, PubMed 30698384
  143. Hoffmann-Vold AM, Didriksen H, Molberg Ø (2019)
    Reply
    Arthritis Rheumatol, 71 (4), 655-656
    DOI 10.1002/art.40816, PubMed 30663863
  144. Elhai M, Hoffmann-Vold AM, Avouac J, Pezet S, Cauvet A, Leblond A, Fretheim H, Garen T, Kuwana M, Molberg Ø, Allanore Y (2019)
    Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease
    Arthritis Rheumatol, 71 (6), 972-982
    DOI 10.1002/art.40815, PubMed 30624031
  145. Hoffmann-Vold AM, Weigt SS, Palchevskiy V, Volkmann E, Saggar R, Li N, Midtvedt Ø, Lund MB, Garen T, Fishbein MC, Ardehali A, Ross DJ, Ueland T, Aukrust P, Lynch JP, Elashoff RM, Molberg Ø, Belperio JA (2018)
    Augmented concentrations of CX3CL1 are associated with interstitial lung disease in systemic sclerosis
    PLoS One, 13 (11), e0206545
    DOI 10.1371/journal.pone.0206545, PubMed 30457999
  146. Pekala PA, Henry BM, Taterra D, Piwowar M, Vikse J, Tubbs RS, Tomaszewski KA (2018)
    FokI as a genetic factor of intervertebral disc degeneration: A PRISMA-compliant systematic review of overlapping meta-analyses
    J Clin Neurosci, 60, 36-43
    DOI 10.1016/j.jocn.2018.09.028, PubMed 30309807
  147. Tennøe AH, Murbræch K, Andreassen JC, Fretheim H, Garen T, Gude E, Andreassen A, Aakhus S, Molberg Ø, Hoffmann-Vold AM (2018)
    Left Ventricular Diastolic Dysfunction Predicts Mortality in Patients With Systemic Sclerosis
    J Am Coll Cardiol, 72 (15), 1804-1813
    DOI 10.1016/j.jacc.2018.07.068, PubMed 30286924
  148. Hoffmann-Vold AM, Molberg Ø (2018)
    CCL21 as a potential biomarker for pulmonary arterial hypertension in systemic sclerosis
    Arthritis Rheumatol (in press)
    DOI 10.1002/art.40740, PubMed 30281215
  149. Garen T, Lerang K, Hoffmann-Vold AM, Andersson H, Midtvedt Ø, Brunborg C, Kilian K, Gudbrandsson B, Gunnarsson R, Norby G, Chaudhary A, Thoen J, Forseth KØ, Fresjar K, Førre Ø, Haugen M, Haga HJ, Gran JT, Gilboe IM, Molberg Ø, Palm Ø (2019)
    Mortality and causes of death across the systemic connective tissue diseases and the primary systemic vasculitides
    Rheumatology (Oxford), 58 (2), 313-320
    DOI 10.1093/rheumatology/key285, PubMed 30281089
  150. Henry BM, Hsieh WC, Sanna B, Vikse J, Taterra D, Tomaszewski KA (2018)
    Incidence, Risk Factors, and Comorbidities of Vocal Cord Paralysis After Surgical Closure of a Patent Ductus Arteriosus: A Meta-analysis
    Pediatr Cardiol, 40 (1), 116-125
    DOI 10.1007/s00246-018-1967-8, PubMed 30167748
  151. Wu W, Jordan S, Becker MO, Dobrota R, Maurer B, Fretheim H, Ye S, Siegert E, Allanore Y, Hoffmann-Vold AM, Distler O (2018)
    Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model
    Ann Rheum Dis, 77 (9), 1326-1332
    DOI 10.1136/annrheumdis-2018-213201, PubMed 29875097
  152. Hoffmann-Vold AM, Hesselstrand R, Fretheim H, Ueland T, Andreassen AK, Brunborg C, Palchevskiy V, Midtvedt Ø, Garen T, Aukrust P, Belperio JA, Molberg Ø (2018)
    CCL21 as a Potential Serum Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis
    Arthritis Rheumatol, 70 (10), 1644-1653
    DOI 10.1002/art.40534, PubMed 29687634
  153. Henry BM, Vikse J, Pekala P, Loukas M, Tubbs RS, Walocha JA, Jones DG, Tomaszewski KA (2018)
    Consensus guidelines for the uniform reporting of study ethics in anatomical research within the framework of the anatomical quality assurance (AQUA) checklist
    Clin Anat, 31 (4), 521-524
    DOI 10.1002/ca.23069, PubMed 29532521
  154. Vikse J, Ørn S, Jeroen de Romijn B, Greve OJ, Norheim KB (2018)
    [Cardiac sarcoidosis]
    Tidsskr Nor Laegeforen, 138 (4)
    DOI 10.4045/tidsskr.17.0701, PubMed 29460602
  155. Henry BM, Skinningsrud B, Vikse J, Pękala PA, Walocha JA, Loukas M, Tubbs RS, Tomaszewski KA (2018)
    Systematic reviews versus narrative reviews in clinical anatomy: Methodological approaches in the era of evidence-based anatomy
    Clin Anat, 31 (3), 364-367
    DOI 10.1002/ca.23042, PubMed 29322553
  156. Sanna B, Henry BM, Vikse J, Skinningsrud B, Pękala JR, Walocha JA, Cirocchi R, Tomaszewski KA (2017)
    The prevalence and morphology of the corona mortis (Crown of death): A meta-analysis with implications in abdominal wall and pelvic surgery
    Injury, 49 (2), 302-308
    DOI 10.1016/j.injury.2017.12.007, PubMed 29241998
  157. Hoffmann-Vold AM, Fretheim H, Midtvedt Ø, Kilian K, Angelshaug M, Chaudhary A, Gunnarsson R, Brunborg C, Garen T, Andreassen AK, Gude E, Molberg Ø (2018)
    Frequencies of borderline pulmonary hypertension before and after the DETECT algorithm: results from a prospective systemic sclerosis cohort
    Rheumatology (Oxford), 57 (3), 480-487
    DOI 10.1093/rheumatology/kex435, PubMed 29237073
  158. Henry BM, Vikse J, Sanna B, Taterra D, Gomulska M, Pękala PA, Tubbs RS, Tomaszewski KA (2017)
    Cervical Rib Prevalence and its Association with Thoracic Outlet Syndrome: A Meta-Analysis of 141 Studies with Surgical Considerations
    World Neurosurg, 110, e965-e978
    DOI 10.1016/j.wneu.2017.11.148, PubMed 29203316
  159. Vikse J, Klos J, Berg A (2017)
    A travelling camper with a spiking fever, headache, myalgia, hepatitis, and intracellular inclusions
    Lancet Infect Dis, 17 (12), 1318
    DOI 10.1016/S1473-3099(17)30305-5, PubMed 29173891
  160. Vikse J, Zaharia C, Jaatun HJ, Greve OJ, Omdal R, Norheim KB (2017)
    [A woman in her 60s with diarrhea and joint pain]
    Tidsskr Nor Laegeforen, 137 (19)
    DOI 10.4045/tidsskr.17.0195, PubMed 29043718
  161. Vikse J, Håland S, Norheim KB (2017)
    IgG4-related disease
    Tidsskr Nor Laegeforen, 137 (16)
    DOI 10.4045/tidsskr.16.1099, PubMed 28871762
  162. Avouac J, Guignabert C, Hoffmann-Vold AM, Ruiz B, Dorfmuller P, Pezet S, Amar O, Tu L, Van Wassenhove J, Sadoine J, Launay D, Elhai M, Cauvet A, Subramaniam A, Resnick R, Hachulla E, Molberg Ø, Kahan A, Humbert M, Allanore Y (2017)
    Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic Sclerosis
    Arthritis Rheumatol, 69 (11), 2209-2221
    DOI 10.1002/art.40229, PubMed 28805015
  163. Volkmann ER, Hoffmann-Vold AM, Chang YL, Jacobs JP, Tillisch K, Mayer EA, Clements PJ, Hov JR, Kummen M, Midtvedt Ø, Lagishetty V, Chang L, Labus JS, Molberg Ø, Braun J (2017)
    Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohorts
    BMJ Open Gastroenterol, 4 (1), e000134
    DOI 10.1136/bmjgast-2017-000134, PubMed 28761687
  164. Vikse J, Sanna B, Henry BM, Taterra D, Sanna S, Pękala PA, Walocha JA, Tomaszewski KA (2017)
    The prevalence and morphometry of an accessory spleen: A meta-analysis and systematic review of 22,487 patients
    Int J Surg, 45, 18-28
    DOI 10.1016/j.ijsu.2017.07.045, PubMed 28716661
  165. Bossini-Castillo L, Campillo-Davó D, López-Isac E, Carmona FD, Simeon CP, Carreira P, Callejas-Rubio JL, Castellví I, Fernández-Nebro A, Rodríguez-Rodríguez L, Rubio-Rivas M, García-Hernández FJ, Madroñero AB, Beretta L, Santaniello A, Lunardi C, Airó P, Hoffmann-Vold AM, Kreuter A, Riemekasten G, Witte T, Hunzelmann N, Vonk MC, Voskuyl AE, de Vries-Bouwstra J et al. (2017)
    An MIF Promoter Polymorphism Is Associated with Susceptibility to Pulmonary Arterial Hypertension in Diffuse Cutaneous Systemic Sclerosis
    J Rheumatol, 44 (10), 1453-1457
    DOI 10.3899/jrheum.161369, PubMed 28668810
  166. Pękala PA, Henry BM, Pękala JR, Hsieh WC, Vikse J, Sanna B, Walocha JA, Tubbs RS, Tomaszewski KA (2017)
    Prevalence of foramen arcuale and its clinical significance: a meta-analysis of 55,985 subjects
    J Neurosurg Spine, 27 (3), 276-290
    DOI 10.3171/2017.1.SPINE161092, PubMed 28621616
  167. Vikse J, Gjøse BF (2017)
    [Hypoxia or hypoxemia?]
    Tidsskr Nor Laegeforen, 137 (7), 554
    DOI 10.4045/tidsskr.16.1146, PubMed 28383233
  168. Henry BM, Graves MJ, Vikse J, Sanna B, Pękala PA, Walocha JA, Barczyński M, Tomaszewski KA (2017)
    The current state of intermittent intraoperative neural monitoring for prevention of recurrent laryngeal nerve injury during thyroidectomy: a PRISMA-compliant systematic review of overlapping meta-analyses
    Langenbecks Arch Surg, 402 (4), 663-673
    DOI 10.1007/s00423-017-1580-y, PubMed 28378238
  169. Henry BM, Sanna B, Vikse J, Graves MJ, Spulber A, Witkowski C, Tomaszewska IM, Tubbs RS, Tomaszewski KA (2017)
    Zuckerkandl's tubercle and its relationship to the recurrent laryngeal nerve: A cadaveric dissection and meta-analysis
    Auris Nasus Larynx, 44 (6), 639-647
    DOI 10.1016/j.anl.2017.03.013, PubMed 28377109
  170. Volkmann ER, Tashkin DP, Li N, Roth MD, Khanna D, Hoffmann-Vold AM, Kim G, Goldin J, Clements PJ, Furst DE, Elashoff RM (2017)
    Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II
    Arthritis Rheumatol, 69 (7), 1451-1460
    DOI 10.1002/art.40114, PubMed 28376288
  171. Henry BM, Sanna S, Graves MJ, Vikse J, Sanna B, Tomaszewska IM, Tubbs RS, Walocha JA, Tomaszewski KA (2017)
    The Non-Recurrent Laryngeal Nerve: a meta-analysis and clinical considerations
    PeerJ, 5, e3012
    DOI 10.7717/peerj.3012, PubMed 28344898
  172. Henry BM, Sanna B, Graves MJ, Sanna S, Vikse J, Tomaszewska IM, Tubbs RS, Tomaszewski KA (2017)
    The Reliability of the Tracheoesophageal Groove and the Ligament of Berry as Landmarks for Identifying the Recurrent Laryngeal Nerve: A Cadaveric Study and Meta-Analysis
    Biomed Res Int, 2017, 4357591
    DOI 10.1155/2017/4357591, PubMed 28271065
  173. Henry BM, Pękala PA, Vikse J, Sanna B, Skinningsrud B, Saganiak K, Walocha JA, Tomaszewski KA (2017)
    Variations in the Arterial Blood Supply to the Penis and the Accessory Pudendal Artery: A Meta-Analysis and Review of Implications in Radical Prostatectomy
    J Urol, 198 (2), 345-353
    DOI 10.1016/j.juro.2017.01.080, PubMed 28202357
  174. Hoffmann-Vold AM, Midtvedt Ø, Tennøe AH, Garen T, Lund MB, Aaløkken TM, Andreassen AK, Elhage F, Brunborg C, Taraldsrud E, Molberg Ø (2017)
    Cardiopulmonary Disease Development in Anti-RNA Polymerase III-positive Systemic Sclerosis: Comparative Analyses from an Unselected, Prospective Patient Cohort
    J Rheumatol, 44 (4), 459-465
    DOI 10.3899/jrheum.160867, PubMed 28089974
  175. Henry BM, Pękala PA, Sanna B, Vikse J, Sanna S, Saganiak K, Tomaszewska IM, Tubbs RS, Tomaszewski KA (2016)
    The Anastomoses of the Recurrent Laryngeal Nerve in the Larynx: A Meta-Analysis and Systematic Review
    J Voice, 31 (4), 495-503
    DOI 10.1016/j.jvoice.2016.11.004, PubMed 27939121
  176. Tomaszewski KA, Henry BM, Kumar Ramakrishnan P, Roy J, Vikse J, Loukas M, Tubbs RS, Walocha JA (2016)
    Development of the Anatomical Quality Assurance (AQUA) checklist: Guidelines for reporting original anatomical studies
    Clin Anat, 30 (1), 14-20
    DOI 10.1002/ca.22800, PubMed 27801507
  177. Henry BM, Tomaszewski KA, Ramakrishnan PK, Roy J, Vikse J, Loukas M, Tubbs RS, Walocha JA (2016)
    Development of the anatomical quality assessment (AQUA) tool for the quality assessment of anatomical studies included in meta-analyses and systematic reviews
    Clin Anat, 30 (1), 6-13
    DOI 10.1002/ca.22799, PubMed 27718281
  178. Henry BM, Vikse J, Graves MJ, Sanna S, Sanna B, Tomaszewska IM, Hsieh WC, Tubbs RS, Tomaszewski KA (2016)
    Variable relationship of the recurrent laryngeal nerve to the inferior thyroid artery: A meta-analysis and surgical implications
    Head Neck, 39 (1), 177-186
    DOI 10.1002/hed.24582, PubMed 27627737
  179. Molberg Ø, Hoffmann-Vold AM (2016)
    Interstitial lung disease in systemic sclerosis: progress in screening and early diagnosis
    Curr Opin Rheumatol, 28 (6), 613-8
    DOI 10.1097/BOR.0000000000000323, PubMed 27387267
  180. Vikse J, Cacic DL, Carlsen A, Cooper TJ, Grimstad T (2016)
    A man in his 30s with ulcerative colitis and pancytopenia
    Tidsskr Nor Laegeforen, 136 (11), 1010-4
    DOI 10.4045/tidsskr.15.0958, PubMed 27325035
  181. Elhai M, Avouac J, Hoffmann-Vold AM, Ruzehaji N, Amiar O, Ruiz B, Brahiti H, Ponsoye M, Fréchet M, Burgevin A, Pezet S, Sadoine J, Guilbert T, Nicco C, Akiba H, Heissmeyer V, Subramaniam A, Resnick R, Molberg Ø, Kahan A, Chiocchia G, Allanore Y (2016)
    OX40L blockade protects against inflammation-driven fibrosis
    Proc Natl Acad Sci U S A, 113 (27), E3901-10
    DOI 10.1073/pnas.1523512113, PubMed 27298374
  182. Henry BM, Vikse J, Graves MJ, Sanna S, Sanna B, Tomaszewska IM, Tubbs RS, Tomaszewski KA (2016)
    Extralaryngeal branching of the recurrent laryngeal nerve: a meta-analysis of 28,387 nerves
    Langenbecks Arch Surg, 401 (7), 913-923
    DOI 10.1007/s00423-016-1455-7, PubMed 27251487
  183. Tomaszewski KA, Roy J, Vikse J, Pękala PA, Kopacz P, Henry BM (2016)
    Prevalence of the accessory deep peroneal nerve: A cadaveric study and meta-analysis
    Clin Neurol Neurosurg, 144, 105-11
    DOI 10.1016/j.clineuro.2016.03.026, PubMed 27038872
  184. Hoffmann-Vold AM, Tennøe AH, Garen T, Midtvedt Ø, Abraityte A, Aaløkken TM, Lund MB, Brunborg C, Aukrust P, Ueland T, Molberg Ø (2016)
    High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis
    Chest, 150 (2), 299-306
    DOI 10.1016/j.chest.2016.03.004, PubMed 26997242
  185. Tomaszewski KA, Henry BM, Vikse J, Roy J, Pękala PA, Svensen M, Guay DL, Saganiak K, Walocha JA (2016)
    The origin of the medial circumflex femoral artery: a meta-analysis and proposal of a new classification system
    PeerJ, 4, e1726
    DOI 10.7717/peerj.1726, PubMed 26966661
  186. Vikse J, Henry BM, Roy J, Ramakrishnan PK, Hsieh WC, Walocha JA, Tomaszewski KA (2016)
    Correction: Anatomical Variations in the Sinoatrial Nodal Artery: A Meta-Analysis and Clinical Considerations
    PLoS One, 11 (3), e0150051
    DOI 10.1371/journal.pone.0150051, PubMed 26930468
  187. Tomaszewski KA, Graves MJ, Henry BM, Popieluszko P, Roy J, Pękala PA, Hsieh WC, Vikse J, Walocha JA (2016)
    Surgical anatomy of the sciatic nerve: A meta-analysis
    J Orthop Res, 34 (10), 1820-1827
    DOI 10.1002/jor.23186, PubMed 26856540
  188. Vikse J, Henry BM, Roy J, Ramakrishnan PK, Hsieh WC, Walocha JA, Tomaszewski KA (2016)
    Anatomical Variations in the Sinoatrial Nodal Artery: A Meta-Analysis and Clinical Considerations
    PLoS One, 11 (2), e0148331
    DOI 10.1371/journal.pone.0148331, PubMed 26849441
  189. Tomaszewski KA, Henry BM, Vikse J, Pękala P, Roy J, Svensen M, Guay D, Hsieh WC, Loukas M, Walocha JA (2016)
    Variations in the origin of the deep femoral artery: A meta-analysis
    Clin Anat, 30 (1), 106-113
    DOI 10.1002/ca.22691, PubMed 26780216
  190. Hoffmann-Vold AM (2015)
    Dr. Hoffmann-Vold replies
    J Rheumatol, 42 (12), 2513
    DOI 10.3899/jrheum.150886, PubMed 26628710
  191. Roy J, Henry BM, PĘkala PA, Vikse J, Saganiak K, Walocha JA, Tomaszewski KA (2016)
    Median and ulnar nerve anastomoses in the upper limb: A meta-analysis
    Muscle Nerve, 54 (1), 36-47
    DOI 10.1002/mus.24993, PubMed 26599506
  192. Roy J, Henry BM, Pękala PA, Vikse J, Ramakrishnan PK, Walocha JA, Tomaszewski KA (2015)
    The prevalence and anatomical characteristics of the accessory head of the flexor pollicis longus muscle: a meta-analysis
    PeerJ, 3, e1255
    DOI 10.7717/peerj.1255, PubMed 26557419
  193. Henry BM, Roy J, Ramakrishnan PK, Vikse J, Tomaszewski KA, Walocha JA (2015)
    Procalcitonin as a Serum Biomarker for Differentiation of Bacterial Meningitis From Viral Meningitis in Children: Evidence From a Meta-Analysis
    Clin Pediatr (Phila), 55 (8), 749-64
    DOI 10.1177/0009922815606414, PubMed 26378091
  194. Ramakrishnan PK, Henry BM, Vikse J, Roy J, Saganiak K, Mizia E, Tomaszewski KA (2015)
    Anatomical variations of the formation and course of the sural nerve: A systematic review and meta-analysis
    Ann Anat, 202, 36-44
    DOI 10.1016/j.aanat.2015.08.002, PubMed 26342158
  195. Reiseter S, Molberg Ø, Gunnarsson R, Lund MB, Aalokken TM, Aukrust P, Ueland T, Garen T, Brunborg C, Michelsen A, Abraityte A, Hoffmann-Vold AM (2015)
    Associations between circulating endostatin levels and vascular organ damage in systemic sclerosis and mixed connective tissue disease: an observational study
    Arthritis Res Ther, 17 (1), 231
    DOI 10.1186/s13075-015-0756-5, PubMed 26315510
  196. Henry BM, Zwinczewska H, Roy J, Vikse J, Ramakrishnan PK, Walocha JA, Tomaszewski KA (2015)
    The Prevalence of Anatomical Variations of the Median Nerve in the Carpal Tunnel: A Systematic Review and Meta-Analysis
    PLoS One, 10 (8), e0136477
    DOI 10.1371/journal.pone.0136477, PubMed 26305098
  197. Henry BM, Roy J, Ramakrishnan PK, Vikse J, Tomaszewski KA, Walocha JA (2015)
    Association of migraine headaches with anatomical variations of the Circle of Willis: Evidence from a meta-analysis
    Neurol Neurochir Pol, 49 (4), 272-7
    DOI 10.1016/j.pjnns.2015.06.002, PubMed 26188945
  198. Vikse J, Henry BM, Roy J, Ramakrishnan PK, Tomaszewski KA, Walocha JA (2015)
    The role of serum procalcitonin in the diagnosis of bacterial meningitis in adults: a systematic review and meta-analysis
    Int J Infect Dis, 38, 68-76
    DOI 10.1016/j.ijid.2015.07.011, PubMed 26188130
  199. Hoffmann-Vold AM, Aaløkken TM, Lund MB, Garen T, Midtvedt Ø, Brunborg C, Gran JT, Molberg Ø (2015)
    Predictive value of serial high-resolution computed tomography analyses and concurrent lung function tests in systemic sclerosis
    Arthritis Rheumatol, 67 (8), 2205-12
    DOI 10.1002/art.39166, PubMed 25916462
  200. Hoffmann-Vold AM, Gunnarsson R, Garen T, Midtvedt Ø, Molberg Ø (2014)
    Performance of the 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis (SSc) in large, well-defined cohorts of SSc and mixed connective tissue disease
    J Rheumatol, 42 (1), 60-3
    DOI 10.3899/jrheum.140047, PubMed 25274890
  201. Bergersen TK, Hoffmann-Vold AM, Midtvedt Ø, Gran JT, Mørk C, Toska K, Elstad M (2014)
    Dysfunctional arteriovenous anastomoses in hands of systemic sclerosis patients with digital ulcers
    Clin Exp Rheumatol, 32 (6 Suppl 86), S-53-9
    PubMed 24847906
  202. Hoffmann-Vold AM, Molberg Ø, Midtvedt Ø, Garen T, Gran JT (2013)
    Survival and causes of death in an unselected and complete cohort of Norwegian patients with systemic sclerosis
    J Rheumatol, 40 (7), 1127-33
    DOI 10.3899/jrheum.121390, PubMed 23637316
  203. Diaz-Gallo LM, Simeon CP, Broen JC, Ortego-Centeno N, Beretta L, Vonk MC, Carreira PE, Vargas S, Román-Ivorra JA, González-Gay MA, Tolosa C, López-Longo FJ, Espinosa G, Vicente EF, Hesselstrand R, Riemekasten G, Witte T, Distler JH, Voskuyl AE, Schuerwegh AJ, Shiels PG, Nordin A, Padyukov L, Hoffmann-Vold AM, Scorza R et al. (2012)
    Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility
    Ann Rheum Dis, 72 (7), 1233-8
    DOI 10.1136/annrheumdis-2012-202357, PubMed 23172754
  204. Bossini-Castillo L, Martin JE, Broen J, Simeon CP, Beretta L, Gorlova OY, Vonk MC, Ortego-Centeno N, Espinosa G, Carreira P, García de la Peña P, Oreiro N, Román-Ivorra JA, Castillo MJ, González-Gay MA, Sáez-Comet L, Castellví I, Schuerwegh AJ, Voskuyl AE, Hoffmann-Vold AM, Hesselstrand R, Nordin A, Lunardi C, Scorza R, van Laar JM et al. (2012)
    Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study
    Ann Rheum Dis, 72 (4), 602-7
    DOI 10.1136/annrheumdis-2012-201888, PubMed 22896740
  205. Hoffmann-Vold AM, Midtvedt Ø, Molberg Ø, Garen T, Gran JT (2012)
    Prevalence of systemic sclerosis in south-east Norway
    Rheumatology (Oxford), 51 (9), 1600-5
    DOI 10.1093/rheumatology/kes076, PubMed 22539477
  206. Bossini-Castillo L, Simeon CP, Beretta L, Broen JC, Vonk MC, Ríos-Fernández R, Espinosa G, Carreira P, Camps MT, Castillo MJ, González-Gay MA, Beltrán E, Carmen Freire Md, Narváez J, Tolosa C, Witte T, Kreuter A, Schuerwegh AJ, Hoffmann-Vold AM, Hesselstrand R, Lunardi C, van Laar JM, Chee MM, Herrick A, Koeleman BP et al. (2012)
    A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosis
    Arthritis Res Ther, 14 (2), R85
    DOI 10.1186/ar3809, PubMed 22531499
  207. Bossini-Castillo L, Simeon CP, Beretta L, Vonk MC, Callejas-Rubio JL, Espinosa G, Carreira P, Camps MT, Rodríguez-Rodríguez L, Rodríguez-Carballeira M, García-Hernández FJ, López-Longo FJ, Hernández-Hernández V, Sáez-Comet L, Egurbide MV, Hesselstrand R, Nordin A, Hoffmann-Vold AM, Vanthuyne M, Smith V, De Langhe E, Kreuter A, Riemekasten G, Witte T, Hunzelmann N et al. (2011)
    Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population
    Rheumatology (Oxford), 50 (11), 1976-81
    DOI 10.1093/rheumatology/ker259, PubMed 21875883
  208. Gorlova O, Martin JE, Rueda B, Koeleman BP, Ying J, Teruel M, Diaz-Gallo LM, Broen JC, Vonk MC, Simeon CP, Alizadeh BZ, Coenen MJ, Voskuyl AE, Schuerwegh AJ, van Riel PL, Vanthuyne M, van 't Slot R, Italiaander A, Ophoff RA, Hunzelmann N, Fonollosa V, Ortego-Centeno N, González-Gay MA, García-Hernández FJ, González-Escribano MF et al. (2011)
    Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy
    PLoS Genet, 7 (7), e1002178
    DOI 10.1371/journal.pgen.1002178, PubMed 21779181
  209. Carmona FD, Simeon CP, Beretta L, Carreira P, Vonk MC, Ríos-Fernández R, Espinosa G, Navarrete N, Vicente-Rabaneda E, Rodríguez-Rodríguez L, Tolosa C, García-Hernández FJ, Castellví I, Egurbide MV, Fonollosa V, González-Gay MA, Rodríguez-Carballeira M, Díaz-Gónzalez F, Sáez-Comet L, Hesselstrand R, Riemekasten G, Witte T, Voskuyl AE, Schuerwegh AJ, Madhok R et al. (2011)
    Association of a non-synonymous functional variant of the ITGAM gene with systemic sclerosis
    Ann Rheum Dis, 70 (11), 2050-2
    DOI 10.1136/ard.2010.148874, PubMed 21571730
  210. Radstake TR, Gorlova O, Rueda B, Martin JE, Alizadeh BZ, Palomino-Morales R, Coenen MJ, Vonk MC, Voskuyl AE, Schuerwegh AJ, Broen JC, van Riel PL, van 't Slot R, Italiaander A, Ophoff RA, Riemekasten G, Hunzelmann N, Simeon CP, Ortego-Centeno N, González-Gay MA, González-Escribano MF, Spanish Scleroderma Group, Airo P, van Laar J, Herrick A et al. (2010)
    Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus
    Nat Genet, 42 (5), 426-9
    DOI 10.1038/ng.565, PubMed 20383147
  211. Flatø B, Hoffmann-Vold AM, Reiff A, Førre Ø, Lien G, Vinje O (2006)
    Long-term outcome and prognostic factors in enthesitis-related arthritis: a case-control study
    Arthritis Rheum, 54 (11), 3573-82
    DOI 10.1002/art.22181, PubMed 17075863
  212. Vikse J, Saeland C, Ogne C, Greve OJ, Johnsen SJA (2019)
    Aneurysms in coronary arteries
    Tidsskr. Nor. Laegeforen., 139 (2), 174-175
  213. Kreuter M, Hoffmann-Vold AM (2019)
    New ways in the treatment of SSc-ILD: what makes sense?
    Pneumologe, 16 (5), 303-304
    DOI 10.1007/s10405-019-0269-z
  214. Vikse J, Saeveras MZ, Staal EM, Goransson LG (2019)
    Purple urine bag syndrome
    Tidsskr. Nor. Laegeforen., 139 (6), 543-544
  215. Vikse J, Haland S, Norheim KB (2017)
    IgG4-related disease
    Tidsskr. Nor. Laegeforen., 137 (16), 1201-1204
  216. Vikse J, Johnsen SJA, Ronning B, Wildhagen K, Bryne K, Omdal R (2019)
    Tubulointerstitial nephritis and uveitis syndrome
    Tidsskr. Nor. Laegeforen., 139 (8), 736-738
  217. Vikse J, Zaharia C, Jaatun HJ, Greve OJ, Omdal R, Norheim KB (2017)
    A 60-year-old woman with diarrhea and joint pain
    Tidsskr. Nor. Laegeforen., 137 (19), 1524-1528

 
Scroll to top